Breast Cancer Clinical Trial
Official title:
Effectiveness of Home-based Exercise in Quality of Life and Physical Fitness in Older Woman in Breast Cancer Treatment: Randomized Clinical Trial
The purpose of this study is to evaluate the effectiveness of home exercise on quality of life and physical fitness of elderly women with breast cancer patients undergoing cancer treatment.
| Status | Completed |
| Enrollment | 75 |
| Est. completion date | February 2016 |
| Est. primary completion date | February 2016 |
| Accepts healthy volunteers | No |
| Gender | Female |
| Age group | 60 Years to 74 Years |
| Eligibility |
Inclusion Criteria: - Breast cancer diagnosis with stage I or II; - Being in treatment for breast cancer (chemotherapy; radiotherapy and / or hormone therapy). Exclusion Criteria: - Absolute contraindication for physical exercises; - Severe depression diagnosis using the Geriatric Depression Scale; - Malnutrition (wasting grades I, II and III), detected by body mass index (BMI), according to the WHO criteria. |
Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
| Country | Name | City | State |
|---|---|---|---|
| n/a | |||
| Lead Sponsor | Collaborator |
|---|---|
| Professor Fernando Figueira Integral Medicine Institute | Ministry of Health, Brazil |
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Other | Weight | Measurement of body mass, using electronic scale Tanita®. Characterized as continuous numerical variable, measured in kilograms | Change from Baseline in Weight after 12 weeks | No |
| Other | Height | Greater distance between the vertex and the ground when the individual in the standing position, using the stadiometer Sanny® brand. Characterized as continuous numeric variable measured in meters | Change from Baseline in Height after 12 weeks | No |
| Other | Total Muscle Mass Index (IMMT) | Measure of muscle mass relative amount contained in the body, through perimetry using anthropometric tape Sanny® brand. Characterized as continuous numeric variable. | Change from Baseline in Total Muscle Mass Index (IMMT) after 12 weeks | No |
| Other | Fat percentage | as the relative amount of fat contained in the body by means of perimetry using anthropometric Sanny® tape mark. Characterized as continuous numeric variable. | Change from Baseline in Fat percentage after 12 weeks | No |
| Primary | Variation in the performance of Lift and Sitting Test | Test which comprises the Battery Senior Fitness Test (SFT). Evaluates the Lower body strength according to the number of times the individual stood up and sat down in 30 seconds. Characterized as continuous numeric variable. | Change from Baseline in Lift and Sitting Test and after 12 weeks | No |
| Primary | Variation in the performance of Flexion forearm Test | Test which comprises the Battery Senior Fitness Test (SFT). Evaluates the upper body strength according to the number of push-ups of forearm in 30 seconds. Characterized as continuous numeric variable. | Change from Baseline in Flexion forearm Test and after 12 weeks | No |
| Primary | Variation in the performance of Six Minute Walk Test (6MWT) | Test which comprises the Battery Senior Fitness Test (SFT). Evaluates aerobic endurance. Total meters walked for 6 minutes walk. Characterized as continuous numeric variable. | Change from Baseline in Six Minute Walk Test (6MWT) and after 12 weeks | No |
| Primary | Variation in the performance of March Stationary two minutes Test | Test which comprises the Battery Senior Fitness Test (SFT). Evaluates aerobic endurance (alternative test). Total double past stationary in 2 minutes. Characterized as continuous numeric variable. | Change from Baseline in March Stationary two minutes Test and after 12 weeks | No |
| Primary | Variation in the performance of Skip and Vir 2.44 meters test | Test which comprises the Battery Senior Fitness Test (SFT). Assesses motor agility and dynamic balance. Evaluates the time in seconds and hundredths in an established path of 2.44 meters on the route to go and return to starting position. Characterized as continuous numerical variable. | Change from Baseline in Skip and Vir 2.44 meters test and after 12 weeks | No |
| Primary | Variation in the performance of Sit and Reach Modified test (In the Chair) | Test which comprises the Battery Senior Fitness Test (SFT). Evaluates the lower hemisphere flexibility. distance in centimeters reached the tip of the middle fingers and the floor in the sitting position. Characterized as continuous numerical variable. | Change from Baseline in Sit and Reach Modified test (In the Chair) and after 12 weeks | No |
| Primary | Variation in the performance of Flexibility test of the upper limbs | Test which comprises the Battery Senior Fitness Test (SFT). Evaluates the flexibility of the upper limbs. It measures the distance in centimeters between the tips of the fingers in the back area. Characterized as continuous numeric variable. | Change from Baseline in Flexibility test of the upper limbs and after 12 weeks | No |
| Primary | Body Mass Index | the calculation will be determined by the ratio between the weight (in kilograms) and the square of height (in meters). Characterized as continuous numeric variable | Change from Baseline in Body Mass Index and after 12 weeks | No |
| Primary | Variation in the performance of Muscle strength Test | Hand Grip Strength Test. Continuous numeric variable: average kilogram-force (KgF) | Change from Baseline in Muscle strength Test after 12 weeks | No |
| Secondary | Quality of life | Numeric variable: average score from 0 to 100 for 30 issues of questionnaire developed by the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ-C30) | Change from Baseline in Quality of life after 12 weeks | No |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT04681911 -
Inetetamab Combined With Pyrotinib and Chemotherapy in the Treatment of HER2 Positive Metastatic Breast Cancer
|
Phase 2 | |
| Completed |
NCT04890327 -
Web-based Family History Tool
|
N/A | |
| Terminated |
NCT04066790 -
Pyrotinib or Trastuzumab Plus Nab-paclitaxel as Neoadjuvant Therapy in HER2-positive Breast Cancer
|
Phase 2 | |
| Completed |
NCT03591848 -
Pilot Study of a Web-based Decision Aid for Young Women With Breast Cancer, During the Proposal for Preservation of Fertility
|
N/A | |
| Recruiting |
NCT03954197 -
Evaluation of Priming Before in Vitro Maturation for Fertility Preservation in Breast Cancer Patients
|
N/A | |
| Terminated |
NCT02202746 -
A Study to Assess the Safety and Efficacy of the VEGFR-FGFR-PDGFR Inhibitor, Lucitanib, Given to Patients With Metastatic Breast Cancer
|
Phase 2 | |
| Active, not recruiting |
NCT01472094 -
The Hurria Older PatiEnts (HOPE) With Breast Cancer Study
|
||
| Withdrawn |
NCT06057636 -
Hypnosis for Pain in Black Women With Advanced Breast Cancer: A Feasibility Study
|
N/A | |
| Completed |
NCT06049446 -
Combining CEM and Magnetic Seed Localization of Non-Palpable Breast Tumors
|
||
| Recruiting |
NCT05560334 -
A Single-Arm, Open, Exploratory Clinical Study of Pemigatinib in the Treatment of HER2-negative Advanced Breast Cancer Patients With FGFR Alterations
|
Phase 2 | |
| Active, not recruiting |
NCT05501769 -
ARV-471 in Combination With Everolimus for the Treatment of Advanced or Metastatic ER+, HER2- Breast Cancer
|
Phase 1 | |
| Recruiting |
NCT04631835 -
Phase I Study of the HS-10352 in Patients With Advanced Breast Cancer
|
Phase 1 | |
| Completed |
NCT04307407 -
Exercise in Breast Cancer Survivors
|
N/A | |
| Recruiting |
NCT03544762 -
Correlation of 16α-[18F]Fluoro-17β-estradiol PET Imaging With ESR1 Mutation
|
Phase 3 | |
| Terminated |
NCT02482389 -
Study of Preoperative Boost Radiotherapy
|
N/A | |
| Enrolling by invitation |
NCT00068003 -
Harvesting Cells for Experimental Cancer Treatments
|
||
| Completed |
NCT00226967 -
Stress, Diurnal Cortisol, and Breast Cancer Survival
|
||
| Recruiting |
NCT06019325 -
Rhomboid Intercostal Plane Block on Chronic Pain Incidence and Acute Pain Scores After Mastectomy
|
N/A | |
| Recruiting |
NCT06037954 -
A Study of Mental Health Care in People With Cancer
|
N/A | |
| Recruiting |
NCT06006390 -
CEA Targeting Chimeric Antigen Receptor T Lymphocytes (CAR-T) in the Treatment of CEA Positive Advanced Solid Tumors
|
Phase 1/Phase 2 |